3,5-diiodothyropropionic acid
- Generic Name
- 3,5-diiodothyropropionic acid
- Drug Type
- Small Molecule
- Chemical Formula
- C15H12I2O4
- CAS Number
- 1158-10-7
- Unique Ingredient Identifier
- 1HTO2X0SJ9
- Background
DITPA has been investigated in Congestive Heart Failure.
Study of DITPA in Patients With Congestive Heart Failure
Phase 2
Terminated
- Conditions
- Heart Failure, Congestive
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-02-10
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 86
- Registration Number
- NCT00103519
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸Saint Joseph's Research Institute, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)
- First Posted Date
- 2002-03-28
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 150
- Registration Number
- NCT00032643
- Locations
- 🇺🇸
Southern Arizona VA Health Care System, Tucson, Arizona, United States
🇺🇸Ralph H Johnson VA Medical Center, Charleston, Charleston, South Carolina, United States
🇺🇸VA Medical Center, Minneapolis, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath